Results 161 to 170 of about 22,960 (241)

Toward Autonomous Clinics: Human–Robot Collaboration in Clinical Care

open access: yesMedComm, Volume 7, Issue 8, August 2026.
This graphical abstract summarizes the conceptual structure of human–robot collaboration (HRC) for autonomous clinical systems. The framework is organized around a dual‐brain architecture in which a professional brain supports clinical reasoning tasks such as diagnosis, image analysis, treatment planning, and patient monitoring, while a physical brain ...
Xinyuan Wu   +8 more
wiley   +1 more source

Advancing Treatment of Degenerative Eye Diseases at the Nanoscale

open access: yesSmart Medicine, Volume 5, Issue 4, August 2026.
Nanotherapeutics possess the potential to overcome longstanding bottlenecks in treating degenerative ophthalmic diseases. With a highly tunable surface chemistry, nanotechnology platforms can be customized to navigate specific anatomical barriers in the eye and target pathways of diseases.
Li Yao Jin   +5 more
wiley   +1 more source

Lipid mediators regulating intraocular pressure and therapeutic target for glaucoma

open access: yesProceedings for Annual Meeting of The Japanese Pharmacological Society, 2018
openaire   +2 more sources

Injectable Artificial Photoreceptors: STEM Cell Functional Integration and in vivo Electrophysiological Validation in Retinal Degeneration Models

open access: yesSmall Science, Volume 6, Issue 8, August 2026.
Artificial photoreceptors are engineered to efficiently absorb light, with the strongest sensitivity in the green region of the visible spectrum. Upon illumination, they generate electrical signals that activate retinal ganglion cells, which are typically unaffected by disease, enabling transmission of visual information to the brain.
Afshin Izadian   +9 more
wiley   +1 more source

Microenvironment‐Responsive Drug Delivery Systems for Ocular Surface Diseases: Mechanisms, Applications, and Translational Challenges

open access: yesSmall Science, Volume 6, Issue 8, August 2026.
Microenvironment‐responsive drug delivery systems overcome ocular physiological barriers by responding to temperature, pH, ions, reactive oxygen species, and enzymes. This review bridges material design, performance evaluation, and clinical translation, offering actionable insights for treating dry eye disease, infectious keratitis, and corneal ...
Jiamin Liu   +3 more
wiley   +1 more source

Editorial: Exploring new therapeutic frontiers in Glaucoma: from molecular targets to patient outcomes

open access: yesFrontiers in Pharmacology
Silvia Sgambellone   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy